10 results
Appearance of Liver Lesions on Computed Tomography (CT) - Arterial Phase, Portal Venous Phase and Delayed
Appearance of Liver Lesions ... Computed Tomography (CT ... #CT #radiology ... #differential #diagnosis ... #comparison #table
Appearance of Liver Lesions on Various Imaging Modalities
 • Computed Tomography (CT) - Arterial Phase, Portal
Appearance of Liver Lesions ... MRI #POCUS #radiology ... #differential # ... diagnosis #comparison ... #table #appearance
Appearance of Liver Lesions on Contrast Enhanced Ultrasound - Early arterial, Grayscale phase, Late arterial phase,
Appearance of Liver Lesions ... Contrast #POCUS #radiology ... #differential # ... diagnosis #comparison ... #table #appearance
Appearance of Liver Lesions on Magnetic Resonance Imaging (MRI) - T2, T1 precontrast, T1 portal venous,
Appearance of Liver Lesions ... MagneticResonance #radiology ... #differential # ... diagnosis #comparison ... #table #appearance
Fleischner Society recommendations for follow-up of nodules
Previous chest radiographs should be reviewed to determine if the
has been stable ... For lesions with ... Management of indeterminate ... lesions greater ... #Management #Radiology
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Diagnosis and Management ... seen • Chest CT ... residual lesion ... Lung Abscess Differential ... Abscess #pulmonary #differential
Endocarditis Summary

Who?
Infectious:
• Pre-existing valvular disease
• Prosthetic valve
• Congenital heart disease
• IV substance use
• IV catheter
• Recent
Glomerulonephritis Septic ... Marantic (NTBE) Differential ... or destructive lesion ... Endocarditis #diagnosis #management ... #cardiology
Conjunctival Pigmented Lesions: Diagnosis and Management
Pigmented lesions that arise from the conjunctiva include nevus, complexion-associated melanosis
Diagnosis and Management ... is essential to differentiate ... #Diagnosis #Management ... CAM #Melanosis #Comparison ... #Table
Performance Characteristics for Colorectal Cancer Screening Tests
Stool/blood-based tests:
 • FIT: 79% sensitivity, 94% specificity for CRC
mortality 26% • CT ... sensitivity for flat lesions ... Screening #Tests #comparison ... #table #management
ACA Colorectal Cancer Screening Guidelines

When to Screen?
When to Stop?
Family History

Performance Characteristics for Colorectal Cancer Screening Tests
Stool/blood-based
mortality 26% • CT ... sensitivity for flat lesions ... Indications #Tests #comparison ... #table #management